SCHEMBL25789449

SCHEMBL25789449

CC1(C)c2cc(-c3cn4ccccc4n3)ccc2-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4ccc(-c5ccccc5)cc4)n3)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.52
▸ KDM4E B2RXH2 10/20 0.52
▸ NPC1 O15118 9/20 0.52
▸ ALDH1A1 P00352 8/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.52
▸ PKM P14618 4/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ TP53 P04637 2/20 0.52
▸ HPGD P15428 2/20 0.52
▸ TSHR P16473 1/20 0.52
▸ GFER P55789 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ GAA P10253 1/20 0.50
▸ MIF P14174 1/20 0.50
▸ POLB P06746 4/20 0.48
▸ CASP3 P42574 1/20 0.48
▸ SENP8 Q96LD8 1/20 0.48
▸ SENP7 Q9BQF6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25789424 0.99 RAB9A (0.53) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789487 0.95 KDM4E (0.50) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789224 0.92 RAB9A (0.45) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789478 0.90 RAB9A (0.44) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789494 0.90 KDM4E (0.45) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789501 0.90 RAB9A (0.51) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789226 0.87 KDM4E (0.47) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789437 0.86 RAB9A (0.50) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789441 0.86 RAB9A (0.50) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2
SCHEMBL25789123 0.85 RAB9A (0.59) RAB9AKDM4ENPC1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217820-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-07-06 — — US disclosed
US-20230217820-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217820-A1 PLURALITY OF HOST MATERIALS AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME TELO2, SOD1, TERT RAB9A 2202/4885KDM4E 3809/4885NPC1 3704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback